| Cat.No.: | EL-0375 |
| Product Name: | LNCaP nuclear extract (Clone FGC) |
| Description: | LNCaP nuclear extract (Clone FGC) was prepared from cell cultures of the human prostate adenocarcinoma LNCaP-FGC cell line. The LNCaP-FGC cell line is a subclone of the fibroblast-like LNCaP parental cell line that was originally derived from a supraclavicular lymph node metastatic lesion of a 50 year old Caucasian male patient with metastatic prostate carcinoma. Prostate cancer is the second most common neoplasia in men. Because it is a hormone-responsive cancer, its treatment at initial stages of development typically involves anti-androgen adjuvant therapy. The LNCaP-FGC subclone retains all the properties of the parental LNCaP cell line, including its malignant characteristics, such as the expression of high levels of acid phosphatase, androgen receptors and Prostate Specific Antigen (PSA), and hormone sensitivity. This cell line is most commonly used in research as a model for human prostate cancer. |
| Species: | Human |
| Source: | Human epithelial prostate; metastatic site |
| Components: | 200 µg of LNCaP (Clone FGC) nuclear extract at 4.07 µg/µl. |
| Extract Composition: | LNCaP nuclear extract (Clone FGC) is supplied in Dilution Buffer (20 mM Hepes (pH 7.9), 100 mM KCl, 1 mM MgCl2, 20% glycerol, 0.5 mM PMSF and 0.5 mM DTT). |
| Application Notes: | LNCaP nuclear extract (Clone FGC) is specifically recommended for studies related to prostate cancer. |
| Storage: | Store at -80°C. Aliquot to avoid repeated freezing and thawing. |
| Warning: | For research use only, not for diagnostic or therapeutic use. |
| Product Types | ||
| ◆ Extracts & Lysates | ||
| EL-0001 | Recombinant Human MBD1 Cell Lysate | Inquiry |
| EL-0002 | Recombinant Human MBD3 Cell Lysate | Inquiry |
| EL-0003 | Recombinant Human MBD3L1 293 Cell Lysate | Inquiry |
| EL-0004 | Recombinant Human MBD4 Lysate | Inquiry |
| EL-0005 | Recombinant Human MBD5 Cell Lysate | Inquiry |
USA
Enter your email here to subscribe.
Follow us on
Easy access to products and services you need from our library via powerful searching tools
